For women with a history of ischemic stroke, use of vaginal estradiol tablets is not associated with an increased rate of recurrent stroke.

HealthDay News — Metabolic syndrome (MetS) is associated with an increased risk for Parkinson disease (PD), according to a study published online Aug. 20 in Neurology.

The FDA has extended the review for the BLA for clemidsogene lanparvovec for the treatment of MPSII, also known as Hunter Syndrome.

The FDA has issued a CRL to PTC Therapeutics regarding the NDA for vatiquinone for the treatment of children and adults living with Friedreich ataxia.

Families with a child receiving treatment for ASD incur almost 10 times more in health care costs than those of other children.

Higher carbohydrate intake is associated with increased MRI-detected vascular brain injury and reduced cognitive performance.

A remotely delivered behavioral intervention can reduce variability in systolic blood pressure, expressed as the coefficient of variation (BPCoV).

Amyloid PET imaging is associated with significant changes in clinical management across a diverse patient population of older adults with cognitive impairment.

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.

HealthDay News — Adults with hearing loss (HL) with hearing aids have a reduced risk for dementia, according to a research letter published online Aug. 18 in JAMA Neurology.

Among US military personnel, chronic pain and sleep impairment have a bidirectional association that significantly affects quality of life.

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.